kabutan

SAWAI GROUP HOLDINGS Co.,Ltd.(4887) Summary

4887
TSE Prime
SAWAI GROUP HOLDINGS Co.,Ltd.
2,127.0
JPY
-1.0
(-0.05%)
Mar 13, 3:30 pm JST
13.34
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
17.5
PBR
1.37
Yield
2.59%
Margin Trading Ratio
1.39
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
2,111.5 JPY 13.26 USD
Previous Close Mar 12
2,128.0 JPY 13.38 USD
High Mar 13, 10:15 am
2,147.0 JPY 13.49 USD
Low Mar 13, 9:00 am
2,085.0 JPY 13.09 USD
Volume
306,100
Trading Value
0.65B JPY 4.08M USD
VWAP
2125.01 JPY 13.33 USD
Minimum Trading Value
212,700 JPY 1,334 USD
Market Cap
0.25T JPY 1.54B USD
Number of Trades
826
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
1,486
1-Year High May 15, 2025
5,000
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 185,000 34,500 0.19
Feb 27, 2026 188,200 34,400 0.18
Feb 20, 2026 185,900 21,900 0.12
Feb 13, 2026 177,600 21,100 0.12
Feb 6, 2026 188,600 30,800 0.16
Company Profile
SAWAI GROUP HOLDINGS Co., Ltd. is a leading generic pharmaceutical company, specializing in lifestyle disease treatments and anti-cancer drugs. The company is focusing on expanding its business in the United States.
Sector
Pharmaceuticals
SAWAI GROUP HOLDINGS Co., Ltd. primarily engages in the manufacturing and sales of prescription and over-the-counter pharmaceuticals. The group consists of a holding company and eight consolidated subsidiaries, operating under a single segment of "manufacturing and sales of pharmaceuticals and related products." The core company, Sawai Pharmaceutical Co., Ltd., manufactures and sells pharmaceuticals to domestic distributors, wholesalers, other pharmaceutical manufacturers, and medical institutions. Medisa Shinyaku Co., Ltd. handles the sales of prescription drugs, while Kaken Shoyaku Co., Ltd. is responsible for the manufacturing and sales of prescription drugs and the supply of primary raw materials. Trust Pharmatech Co., Ltd. manufactures and sells prescription drugs and is entrusted with part of the research and development and manufacturing operations from Sawai Pharmaceutical. The group as a whole strives for efficient business operations and aims to strengthen its competitiveness in the pharmaceutical market.